Efficacy of interventions for prevention of chemotherapy-induced alopecia: A systematic review and meta-analysis

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages E442-E454

  Shin, Hyoseung ^a   Jo, Seong Jin ^b   Kim, Do Hun ^a   Kwon, Ohsang ^b   Myung, Seung Kwon ^c  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Research Institute and Hospital   (South Korea)

Author keywords

Alopecia; Controlled clinical trials; Hair; Induction chemotherapy; Meta analysis; Minoxidil; Neoplasms; Randomized controlled trials; Scalp

Indexed keywords

CYCLOPHOSPHAMIDE; DERMATOLOGICAL AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MINOXIDIL; PANICUM MILIACEUM EXTRACT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ALOPECIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; HUMAN; LONG TERM CARE; META ANALYSIS; MILLET; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PHYTOTHERAPY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; SCALP COMPRESSION; SCALP COOLING; SYSTEMATIC REVIEW; BREAST NEOPLASMS; CHEMICALLY INDUCED; FEMALE; INDUCED HYPOTHERMIA; TREATMENT OUTCOME;

ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84918564346     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29115     Document Type: Review

References (50)

1. Macduff C, Mackenzie T, Hutcheon A, et al. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care 2003;12:154-61.
2. Batchelor D. Hair and cancer chemotherapy: consequences and nursing care-a literature study. Eur J Cancer Care 2001;10:147-63.
3. Dorr VJ. A practitioner's guide to cancer-related alopecia. Semin Oncol 1998;25:562-70.
4. Wang J, Lu Z, Au JL. Protection against chemotherapy-induced alopecia. Pharm Res 2006;23:2505-14.
5. Hesketh PJ, Batchelor D, Golant M, et al. Chemotherapyinduced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 2004;12:543-9.
6. Trueb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg 2009;28:11-4.
7. Parker R. The effectiveness of scalp hypothermia in preventing cyclophosphamide-induced alopecia. Oncol Nurs Forum 1987;14:49-53.
8. Mols F, Van Den Hurk CJ, Vingerhoets AJJM, et al. Scalp cooling to prevent chemotherapyinduced hair loss: practical and clinical considerations. Support Care Cancer 2009;17:181-9.
9. Grevelman EG, Breed WP. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 2005;16:352-8.
10. Katsimbri P, Bamias A, Pavlidis N. Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 2000;36:766-71.
11. Bulow J, Friberg L, Gaardsting O, et al. Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest 1985;45:505-8.
12. Maxwell MB. Scalp tourniquets for chemotherapy-induced alopecia. Am J Nurs 1980;80:900-3.
13. Kennedy M, Packard R, Grant M, et al. The effects of using chemocap on occurrence of chemotherapy-induced alopecia. Oncol nurs forum 1983;10:19-24.
14. Lovejoy NC. Preventing hair loss during adriamycin therapy. Cancer Nurs 1979;2:117-21.
15. Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther 2011;24:432-42.
16. Rodriguez R, Machiavelli M, Leone B, et al. Minoxidil (Mx) as a prophylaxis of doxorubicininduced alopecia. Ann Oncol 1994;5:769-70.
17. Duvic M, Lemak NA, Valero V, et al. A randomized trial of minoxidil in chemotherapyinduced alopecia. J Am Acad Dermatol 1996;35:74-8.
18. Granai CO, Frederickson H, Gajewski W, et al. The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaecol Oncol 1991;12:129-32.
19. Jimenez JJ, Yunis AA. Protection from chemotherapy-induced alopecia by 1, 25-dihydroxyvitamin D3. Cancer Res 1992;52:5123-5.
20. Hidalgo M, Rinaldi D, Medina G, et al. A phase I trial of topical topitriol (calcitriol, 1, 25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia. Anticancer Drugs 1999;10:393-5.
21. Bleiker TO, Nicolaou N, Traulsen J, et al. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Br J Dermatol 2005;153:103-12.
22. Lissoni P, Tancini G, Barni S, et al. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer 1997;5:126-9.
23. Paik SH, Yoon JS, Ryu HH, et al. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia. Exp Dermatol 2013;22:496-9.
24. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed June 12, 2013.
25. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO Offset Publications, 1979. Available at: http://whqlibdoc.who.int/offset/WHO-OFFSET-48.pdf. Accessed December 8, 2013.
26. Villani C, Inghirami P, Pietrangeli D. Prevention by hypothermic cap of antiblastic induced-alopecia. Eur J Gynaecol Oncol 1986;7:15-7.
27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
28. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.0. 0. London: Wiley, 2008. 276-82.
29. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63.
30. Sredni B, Xu RH, Albeck M, et al. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int J Cancer 1996;65:97-103.
31. Ron IG, Kalmus Y, Kalmus Z, et al. Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer 1997;5:136-8.
32. Protiere C, Evans K, Camerlo J, et al. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer 2002;10:529-37.
33. Edelstyn GA, MacDonald M, MacRae KD. Doxorubicininduced hair loss and possible modification by scalp cooling. Lancet 1977;2:253-4.
34. Robinson MH, Jones AC, Durrant KD. Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer. Cancer Treat Rep 1987;71:913-4.
35. Satterwhite B, Zimm S. The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer 1984;54:34-7.
36. Giaccone G, Di Giulio F, Morandini MP, et al. Scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer Nurs 1988;11:170-3.
37. Peck HJ, Mitchell H, Stewart AL. Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. Eur J Oncol Nurs 2000;4:246-8.
38. Gardani G, Cerrone R, Biella C, et al. A casecontrol study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopecia. Minerva Medica 2007;98:661-4.
39. Kargar M, Sarvestani RS, Khojasteh HN, et al. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs 2011;67:2473-7.
40. Van Den Hurk CJG, Breed WPM, Nortier JWR. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 2012;20:3255-60.
41. Betticher DC, Delmore G, Breitenstein U, et al. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support Care Cancer 2013:1-9.
42. Pesce A, Cassuto JP, Joyner MV, et al. Scalp tourniquet in the prevention of chemotherapyinduced alopecia. N Engl J Med 1978;298:1204-5.
43. Alley E, Green R, Schuchter L. Cutaneous toxicities of cancer therapy. Curr Opin Oncol 2002;14:212-6.
44. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. BMJ 2009;339:b2535.
45. Browall M, Gaston-Johansson F, Danielson E. Postmenopausal women with breast cancer: their experiences of the chemotherapy treatment period. Cancer Nurs 2006;29:34-42.
46. Gregory RP CT, Middleton J, Buchanan RB, et al. Prevention of doxorubicin-induced alopecia by scalp hypothermia: relation to degree of cooling. Br Med J 1982;284:1674.
47. Chon SY, Champion RW, Geddes ER, et al. Chemotherapy-induced alopecia. J Am Acad Dermatol 2012;67:e37-47.
48. Forsberg SA. Scalp cooling therapy and cytotoxic treatment. Lancet 2001;357:1134.
49. Lemieux J, Amireault C, Provencher L, et al. Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat 2009;118:547-52.
50. Baker BW, Wilson CL, Davis AL, et al. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant 1991;7:43-7.